Non-invasive imaging of atherosclerosis

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 3, 2012, Pages 205-218

  Joshi, Francis R ^a   Lindsay, Alistair C ^b   Obaid, Daniel R ^a   Falk, Erling ^c   Rudd, James H F ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Atherosclerosis; Imaging; Non invasive

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SODIUM FLUORIDE F 18;

ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE PREDISPOSITION; DISEASE SEVERITY; ECHOGRAPHY; IMAGING SYSTEM; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOLOGIST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOSIS;

ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CORONARY ARTERY DISEASE; HUMANS; PLAQUE, ATHEROSCLEROTIC;

EID: 84860731060     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jer319     Document Type: Review

References (136)

1. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27: 1610-9. (Pubitemid 43954923)
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
3. Leuschner F, Nahrendorf M. Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res 2011;108:593-606.
4. Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL. Imaging atherosclerosis and vulnerable plaque. J Nucl Med 2010;51(Suppl 1):51S-65S.
5. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde J-LJ. Imaging the Vulnerable Plaque. J Am Coll Cardiol 2011;57:1961-79.
6. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74. (Pubitemid 36019640)
7. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:C7-12.
8. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006;113:2320-8. (Pubitemid 43947978)
9. Newby DE. Triggering of acute myocardial infarction: beyond the vulnerable plaque. Heart 2010;96:1247-51.
10. Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004;25: 1077-82. (Pubitemid 38869428)
11. Narula J, Garg P, Achenbach S, Motoyama S, Virmani R, Strauss HW. Arithmetic of vulnerable plaques for noninvasive imaging. Nat Clin Pract Cardiovasc Med 2008; 5(Suppl 2):S2-10.
12. Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:2523-9. (Pubitemid 44607475)
13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75. (Pubitemid 30262927)
14. Cheruvu PK, Finn AV, Gardner C, Caplan J, Goldstein J, Stone GW et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 2007;50:940-9. (Pubitemid 47313605)
15. Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004;110:278-84. (Pubitemid 38960797)
16. Waxman S, Ishibashi F, Muller JE. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 2006;114:2390-411. (Pubitemid 44848285)
17. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92: 1355-74.
18. Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009;218:7-29.
19. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349:2316-25. (Pubitemid 37509739)
20. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-9. (Pubitemid 47313602)
21. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001;16:285-92. (Pubitemid 32953605)
22. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002;105:939-43. (Pubitemid 34184571)
23. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008;52: 255-62. (Pubitemid 351957849)
24. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. J Am Med Assoc 2004;292:1845-52. (Pubitemid 40169295)
25. Virmani R, Ladich ER, Burke AP, Kolodgie FD. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006;59:S219-27; discussion S213-213.
26. Grønholdt ML, Nordestgaard BG, Bentzon J, Wiebe BM, Zhou J, Falk E et al. Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vasc Surg 2002;35:137-45. (Pubitemid 44725782)
27. Verhoeven BA, Moll FL, Koekkoek JA, van derWal AC, de Kleijn DP, de Vries JP et al. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke 2006;37:2054-60. (Pubitemid 44309903)
28. Li ZY, Howarth SP, Tang T, Gillard JH. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 2006;37: 1195-9. (Pubitemid 43731861)
29. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94. (Pubitemid 27391409)
30. de Groot E, Jukema JW, van Boven AJ, Reiber JH, Zwinderman AH, Lie KI et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am J Cardiol 1995;76:40C-6C.
31. Owen DR, Shalhoub J, Miller S, Gauthier T, Doryforou O, Davies AH et al. Inflammation within carotid atherosclerotic plaque: assessment with late-phase contrast-enhanced US. Radiology 2010;255:638-44.
32. Giannarelli C, Ibanez B, Cimmino G, Garcia Ruiz JM, Faita F, Bianchini E et al. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc Imaging 2010;3: 1256-64.
33. Hoogi A, Adam D, Hoffman A, Kerner H, Reisner S, Gaitini D. Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation. AJR Am J Roentgenol 2011;196:431-6.
34. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation 2007;116:276-84. (Pubitemid 47196563)
35. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005;36:1904-9. (Pubitemid 41266524)
36. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 2002;106:1368-73. (Pubitemid 35013040)
37. Cai J, Hatsukami TS, Ferguson MS, Kerwin WS, Saam T, Chu B et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112:3437-44. (Pubitemid 43739559)
38. Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003;107:851-6. (Pubitemid 36241043)
39. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959-64. (Pubitemid 30656003)
40. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002;105:181-5. (Pubitemid 34084316)
41. Lindsay AC, Biasiolli L, Lee JMS, Kylintireas I, MacIntosh BJ, Watt H et al. Acute 3T magnetic resonance imaging reveals features of carotid atherosclerotic plaque associated with ipsilateral cerebral infarction in minor stroke and transient ischemic attack. JACC Cardiovasc Imaging 2012; (in press).
42. Wasserman BA, Wityk RJ, Trout HH, Virmani R. Low-grade carotid stenosis: looking beyond the lumen with MRI. Stroke 2005;36:2504-13. (Pubitemid 41566989)
43. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345:1863-9. (Pubitemid 33716560)
44. Weber OM, Martin AJ, Higgins CB. Whole-heart steady-state free precession coronary artery magnetic resonance angiography. Magn Reson Med 2003;50: 1223-8. (Pubitemid 37494023)
45. Sakuma H, Ichikawa Y, Chino S, Hirano T, Makino K, Takeda K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006;48:1946-50. (Pubitemid 44738453)
46. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G et al. Non-invasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506-10. (Pubitemid 30639967)
47. Miao C, Chen S, Macedo R, Lai S, Liu K, Li D et al. Positive remodeling of the coronary arteries detected by magnetic resonance imaging in an asymptomatic population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53:1708-15.
48. Tanaka A, Kawasaki T, Noguchi T, Koga S, Hiramatsu Y, Fukuyama T et al. Hyperintense plaque with noncontrast T1-weighted magnetic resonance coronary plaque imaging leading to acute coronary syndrome. Circulation 2009;120: 2400-1.
49. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF et al. Effects of aggressive vs. conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005;46:106-12. (Pubitemid 40905137)
50. Lee JM, Robson MD, Yu LM, Shirodaria CC, Cunnington C, Kylintireas I et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009;54:1787-94.
51. Zhao XQ, Dong L, Hatsukami T, Phan BA, Chu B, Moore A et al. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging 2011;4:977-86.
52. McAteer MA, Schneider JE, Ali ZA, Warrick N, Bursill CA, von zur Muhlen C et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler Thromb Vasc Biol 2008;28:77-83.
53. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, U-King-Im JM et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009;53:2039-50.
54. Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED et al. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis 2002;162: 315-21. (Pubitemid 34457937)
55. Davies JR, Rudd JH, Weissberg PL, Narula J. Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol 2006;47:C57-68.
56. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 2007;48:932-45. (Pubitemid 46909922)
57. Björnheden T, Levin M, Evaldsson M, Wiklund O. Evidence of hypoxic areas within the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1999;19:870-6. (Pubitemid 29177331)
58. Mayr M, Sidibe A, Zampetaki A. The paradox of hypoxic and oxidative stress in atherosclerosis. J Am Coll Cardiol 2008;51:1266-7.
59. Leppänen O, Björnheden T, Evaldsson M, Borén J, Wiklund O, Levin M. ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. Atherosclerosis 2006;188:323-30. (Pubitemid 44301139)
60. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 2001;26:314-9. (Pubitemid 32226294)
61. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H et al. Non-invasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294-301. (Pubitemid 40790404)
62. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K et al. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment With FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging 2011;4:1100-9.
63. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11. (Pubitemid 34615139)
64. Kwee RM, Truijman MT, Mess WH, Teule GJ, Ter Berg JW, Franke CL et al. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/ CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol 2011;32:950-4.
65. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a non-invasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818-24. (Pubitemid 44648622)
66. Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 2003;30:267-73. (Pubitemid 36686846)
67. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK et al. Hypoxia but not inflammation augments glucose uptake in human macrophages implications for imaging atherosclerosis with (18)fluorine-labeled 2-deoxy-d-glucose positron emission tomography. J Am Coll Cardiol 2011;58:603-14.
68. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008;51:1258-65. (Pubitemid 351400903)
69. Yun M, Jang S, Cucchiara A, Newberg AB, Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 2002;32:70-6. (Pubitemid 34112944)
70. Tahara N, Kai H, Yamagishi S, Mizoguchi M, Nakaura H, Ishibashi M et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 2007;49: 1533-9. (Pubitemid 46517964)
71. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/ computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107-15.
72. Pedersen SF, Graebe M, Fisker Hag AM, Højgaard L, Sillesen H, Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010;31:423-9.
73. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis 2009;207:139-43.
74. Davies JR, Rudd JH, Fryer TD, Graves MJ, Clark JC, Kirkpatrick PJ et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005;36:2642-7.
75. Moustafa RR, Izquierdo-Garcia D, Fryer TD, Graves MJ, Rudd JH, Gillard JH et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot study. Circ Cardiovasc Imaging 2010;3:536-41.
76. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50:892-6. (Pubitemid 47268746)
77. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825-31. (Pubitemid 44648621)
78. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 2011;4:1110-8.
79. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multi-modality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011;378: 1547-59.
80. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190:W151-6.
81. Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 2009;50:563-8.
82. Rogers IS, Nasir K, Figueroa AL, Cury RC, Hoffmann U, Vermylen DA et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging 2010;3: 388-97.
83. 18F]-FDG PET/CT. Eur Heart J Suppl 2011;13 (suppl A):A1-A112.
84. Teras M, Kokki T, Durand-Schaefer N, Noponen T, Pietila M, Kiss J et al. Dual-gated cardiac PET-clinical feasibility study. Eur J Nucl Med Mol Imaging 2010;37: 505-16.
85. Gaeta C, Fernandez Y, Pavia J, Flotats A, Artigas C, Deportos J et al. Reduced myocardial (18)F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection. Eur J Nucl Med Mol Imaging 2011;38:2018-24.
86. Rominger A, Saam T, Wolpers S, Cyran CC, Schmidt M, Foerster S et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009;50: 1611-20.
87. Muntendam P, McCall C, Sanz J, Falk E, Fuster V. The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease - study design and objectives. Am Heart J 2010;160: 49-57.e1.
88. Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2011; September 19. [Epub ahead of print].
89. Bucerius J, Schmaljohann J, Bohm I, Palmedo H, Guhlke S, Tiemann K et al. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans - first results. Eur J Nucl Med Mol Imaging 2008;35:815-20.
90. Rominger A, Saam T, Vogl E, Ubleis C, la Fougere C, Forster S et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med 2010;51:193-7.
91. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 2008;49: 68-78.
92. Even-Sapir E, Mishani E, Flusser G, Metser U. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography. Semin Nucl Med 2007;37:462-9. (Pubitemid 47505220)
93. Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 2010;51:862-5.
94. Derlin T, Toth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med 2011;52:1020-7.
95. Derlin T, Wisotzki C, Richter U, Apostolova I, Bannas P, Weber C et al. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/ CT: correlation with atherogenic risk factors. J Nucl Med 2011;52:362-8.
96. Li Y, Berenji GR, Shaba WF, Tafti B, Yevdayev E, Dadparvar S. Association of vascular fluoride uptake with vascular calcification and coronary artery disease. Nucl Med Commun 2012;33:14-20.
97. Dweck MR, Jones C, Joshi N, Fletcher AM, Richardson H, White A et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012;125:76-86.
98. Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice. J Nucl Med 2008;49: 1707-14.
99. Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472-3. (Pubitemid 38420011)
100. Hounsfield GN. Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol 1973;46:1016-22.
101. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 2008;52: 1724-32.
102. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 2008; 52:2135-44.
103. Taylor AJ, Cerqueira M, Hodgson JM, Mark D, Min J, O'Gara P et al. ACCF/ SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr 2010;4:407.e401-433.
104. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32. (Pubitemid 20101575)
105. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70. (Pubitemid 46661110)
106. Rosen BD, Fernandes V, McClelland RL, Carr JJ, Detrano R, Bluemke DA et al. Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging 2009;2:1175-83.
107. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H et al. Aggressive vs. moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 2005;112:563-71. (Pubitemid 41060797)
108. McCullough PA, Chinnaiyan KM. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med 2009;169: 2064-70.
109. Becker CR, Knez A, Ohnesorge B, Schoepf UJ, Reiser MF. Imaging of noncalcified coronary plaques using helical CT with retrospective ECG gating. AJR Am J Roentgenol 2000;175:423-4. (Pubitemid 30619192)
110. Voros S, Rinehart S, Qian Z, Joshi P, Vazquez G, Fischer C et al. Coronary atherosclerosis imaging by coronary CT angiography current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 2011;4:537-48.
111. Leschka S, Seitun S, Dettmer M, Baumüller S, Stolzmann P, Goetti R et al. Ex vivo evaluation of coronary atherosclerotic plaques: characterization with dual-source CT in comparison with histopathology. J Cardiovasc Comput Tomogr 2010;4:301-8.
112. Pundziute G, Schuijf JD, Jukema JW, Boersma E, de Roos A, van derWall EE et al. Prognostic value of multislice computed tomography coronary angiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007;49:62-70. (Pubitemid 46026899)
113. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007;50:319-26. (Pubitemid 47058884)
114. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 2009;54:49-57.
115. Schroeder S, Kuettner A, Leitritz M, Janzen J, Kopp AF, Herdeg C et al. Reliability of differentiating human coronary plaque morphology using contrast-enhanced multislice spiral computed tomography: a comparison with histology. J Comput Assist Tomogr 2004;28:449-54. (Pubitemid 38988810)
116. Pohle K, Achenbach S, Macneill B, Ropers D, Ferencik M, Moselewski F et al. Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis 2007;190:174-80. (Pubitemid 44908312)
117. Knollmann F, Ducke F, Krist L, Kertesz T, Meyer R, Guski H et al. Quantification of atherosclerotic coronary plaque components by submillimeter computed tomography. Int J Cardiovasc Imaging 2008;24:301-10.
118. Schoenhagen P, Barreto M, Halliburton SS. Quantitative plaque characterization with coronary CT angiography (CTA): current challenges and future application in atherosclerosis trials and clinical risk assessment. Int J Cardiovasc Imaging 2008; 24:313-6.
119. Brodoefel H, Burgstahler C, Heuschmid M, Reimann A, Khosa F, Kopp A et al. Accuracy of dual-source CT in the characterisation of non-calcified plaque: use of a colour-coded analysis compared with virtual histology intravascular ultrasound. Br J Radiol 2009;82:805-12.
120. Voros S, Rinehart S, Qian Z, Vazquez G, Anderson H, Murrieta L et al. Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: results from the ATLANTA (assessment of tissue characteristics, lesion morphology, and hemodynamics by angiography with fractional flow reserve, intravascular ultrasound and virtual histology, and noninvasive computed tomography in atherosclerotic plaques) I study. JACC Cardiovasc Interv 2011;4:198-208.
121. Inoue K, Motoyama S, Sarai M, Sato T, Harigaya H, Hara T et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging 2010;3:691-8.
122. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364:226-35.
123. Leber AW, Becker A, Knez A, von Ziegler F, Sirol M, Nikolaou K et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 2006;47:672-7. (Pubitemid 43170862)
124. Gauss S, Achenbach S, Pflederer T, Schuhbäck A, Daniel WG, Marwan M. Assessment of coronary artery remodelling by dual-source CT: a head-to-head comparison with intravascular ultrasound. Heart 2011;97:991-7.
125. van Velzen JE, Schuijf JD, de Graaf FR, Nucifora G, Pundziute G, Jukema JW et al. Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosis. Heart 2009;95: 1990-6.
126. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84. (Pubitemid 350190758)
127. Schroeder S, Achenbach S, Bengel F, Burgstahler C, Cademartiri F, de Feyter P et al. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J 2008;29: 531-56. (Pubitemid 351264173)
128. Achenbach S, Marwan M, Ropers D, Schepis T, Pflederer T, Anders K et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J 2010;31:340-6.
129. Leipsic J, Labounty TM, Heilbron B, Min JK, Mancini GB, Lin FY et al. Estimated radiation dose reduction using adaptive statistical iterative reconstruction in coronary CT angiography: the ERASIR study. AJR Am J Roentgenol 2010;195:655-60.
130. Barreto M, Schoenhagen P, Nair A, Amatangelo S, Milite M, Obuchowski NA et al. Potential of dual-energy computed tomography to characterize atherosclerotic plaque: ex vivo assessment of human coronary arteries in comparison to histology. J Cardiovasc Comput Tomogr 2008;2:234-42.
131. Feuerlein S, Roessl E, Proksa R, Martens G, Klass O, Jeltsch M et al. Multienergy photon-counting K-edge imaging: potential for improved luminal depiction in vascular imaging. Radiology 2008;249:1010-6.
132. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007;13:636-41. (Pubitemid 46828482)
133. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP et al. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology. 2010;256:774-82.
134. Silvola JM, Saraste A, Forsback S, Laine VJ, Saukko P, Heinonen SE et al. Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice. Arterioscler Thromb Vasc Biol 2011;31:1011-5.
135. Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V et al. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol 2008;28:1311-7.
136. Greenland P, Polonsky TS. Time for a policy change for coronary artery calcium testing in asymptomatic people? J Am Coll Cardiol 2011;58:1702-4.